Modified patient stem cells as prelude to autologous treatment of muscular dystrophy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18371397.
- Also identified by DOI 10.1016/j.stem.2007.11.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Duchenne muscular dystrophy is a devastating muscle wasting disease for which there is no effective treatment. In this issue of Cell Stem Cell, Benchaouir et al. (2007) demonstrate the delivery of genetically corrected CD133+ patient cells into mice, suggesting a new potential avenue for autologous cell therapy.
Medical subject headings
- Muscular Dystrophies
- Stem Cell Transplantation
- Stem Cells
- Transplantation, Autologous